Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-cell Lymphomas (PTCL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Not applicableUnknownNCT06211881
What this trial is testing

Chi-GVM Regimen for the Treatment of R/R PTCL

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180771
What this trial is testing

Bosmolisib (BR101801) in Participants With R/R PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Boryung Pharmaceutical Co., Ltd 44
Very early researchLooking for participantsNCT07162012
What this trial is testing

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

Who this might be right for
NK/T-cell LymphomaPeripheral T-cell Lymphoma (PTCL)DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT02499627
What this trial is testing

Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting

Who this might be right for
Lymphatic Diseases
Fondazione Italiana Linfomi - ETS 43
Early research (Phase 1)Study completedNCT02567656
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous
Rhizen Pharmaceuticals SA 58
Testing effectiveness (Phase 2)Looking for participantsNCT06151106
What this trial is testing

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma
The First Affiliated Hospital of Xiamen University 33
Testing effectiveness (Phase 2)Looking for participantsNCT05934513
What this trial is testing

GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc. 95
Testing effectiveness (Phase 2)UnknownNCT04052659
What this trial is testing

Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 30
Not applicableEnded earlyNCT01841021
What this trial is testing

Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30

Who this might be right for
Peripheral T-Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 1
Large-scale testing (Phase 3)WithdrawnNCT04021082
What this trial is testing

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma (PTCL NOS)Nodal Lymphomas of T Follicular Helper (TFH)Follicular T-cell Lymphoma (FTCL)+6 more
Portola Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT03355768
What this trial is testing

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Jennifer Amengual
Testing effectiveness (Phase 2)Ended earlyNCT06941688
What this trial is testing

Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (PTCL)
Seoul National University Hospital 17
Early research (Phase 1)Study completedNCT02512497
What this trial is testing

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Who this might be right for
Cutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758491
What this trial is testing

A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
PTCLTRBC1 ADCCTCL
FutureGen Biopharmaceutical (Beijing) Co., Ltd 110
Testing effectiveness (Phase 2)Looking for participantsNCT06495723
What this trial is testing

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06485219
What this trial is testing

A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)
Chengdu Zenitar Biomedical Technology Co., Ltd 50
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Testing effectiveness (Phase 2)WithdrawnNCT03999658
What this trial is testing

STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B Cell LymphomaBiliary Tract Cancer+1 more
Sorrento Therapeutics, Inc.
Next Page